EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates

Prasanna Ram iD, Prasant Nayak, Swarnendu Mandal, Manoj K Das, Sambit Tripathy

The Prostate · 2023

DOI: 10.1002/pros.24487 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Prostate, 2023. Verfasst von Prasanna Ram und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, All India Institute of Medical Sciences, Bhubaneshwar, Odisha, India. Hauptthemen laut MEDLINE: Lasers, Solid-State, Prostatic Hyperplasia, Prostatic Neoplasms, Lower Urinary Tract Symptoms. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, Solid-StateProstatic HyperplasiaProstatic NeoplasmsLower Urinary Tract SymptomsTransurethral Resection of ProstateMaleHumansProstateWatchful WaitingTreatment OutcomeRetrospective Studies

Autor:innen und Institutionen

  • Department of Urology, All India Institute of Medical Sciences, Bhubaneshwar, Odisha, India.

ORCID-Profile: Prasanna Ram

Zitieren

APA

Ram, P., Nayak, P., Mandal, S., Das, M. K., & Tripathy, S. (2023). Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates. The Prostate. https://doi.org/10.1002/pros.24487

Vancouver

Ram P, Nayak P, Mandal S, Das MK, Tripathy S. Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates. The Prostate. 2023. doi:10.1002/pros.24487

BibTeX
@article{Ram2023,
  author = {Ram, Prasanna and Nayak, Prasant and Mandal, Swarnendu and Das, Manoj K and Tripathy, Sambit},
  title = {Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates},
  journal = {The Prostate},
  year = {2023},
  doi = {10.1002/pros.24487}
}
Kostenlos starten →